HCC is the most common tumour diagnosed in Egypt among males. It is also of the main causes of cancer related deaths. According to GLOBOCAN last census, the number of new cases of liver cancer in both sexes, all ages is about 28,000 new cases in the year 2020 representing 27.3% of male and 10.5% of female cancers. 

➡️ Purpose and scope

These guidelines are developed to improve the quality of care for HCC patients Via providing a uniform standard of care across the country to help in primary prevention, screening, early diagnosis for HCC and so less aggressive treatment options and improved clinical outcomes. 

These guidelines cover primary prevention, screening ,diagnosis, staging, treatment and follow-up of HCC.

 ➡️ Target audience

Clinicians who are involved in the care and treatment of patients with advanced HCC, including medical oncologists, radiation oncologists, clinical oncologist, hepatologists, gastroenterologists, surgeons, interventional radiologists, radiologists, pathologists, and palliative care specialists.